Opus - Ac-055-503
Research payments
$2,204,239
Through program year 2019, $2,204,239 in research payments was reported against Opus - Ac-055-503, across 522 payments, paid by Actelion Pharmaceuticals, Ltd.
- Paid by
- Actelion Pharmaceuticals, Ltd
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $2,204,239 | 522 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arunabh Talwar New Hyde Park, NY Named on 8 payments
- Lin-Wang Dong Greeley, CO Named on 8 payments
- Peter Yau Temple, TX Named on 8 payments
- Barry Cabuay Minneapolis, MN Named on 8 payments
- Franck Rahaghi Weston, FL Named on 8 payments
- Jiten Patel Spokane, WA Named on 7 payments
- Mohammad Sheatt Cincinnati, OH Named on 6 payments
- Roham Zamanian Stanford, CA Named on 6 payments
- Vallerie McLaughlin Ann Arbor, MI Named on 6 payments
- David Badesch Aurora, CO Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.